GlassScriptPhysician profile
Robert A Lebby
NPI 1457344129
$1,894.13
in general payments reported to CMS, 2019-2025
14 companies · $286 in 2025
The $286 reported for 2025 was less than what a typical Sleep Medicine (Internal Medicine) provider received nationally (typical 2025 total: $447).
See the full distribution for Sleep Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $242 · 2020: $17.50 · 2021: $252 · 2022: $324 · 2023: $345 · 2024: $427 · 2025: $286.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,000 · Education: $54.99 · Travel and Lodging: $3.33.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,000.27 |
| Education | $54.99 |
| Travel and Lodging | $3.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $599.32 | 2019-2025 | |
| Harmony Biosciences LLC | $251.47 | 2020-2025 | |
| Lilly USA, LLC | $161.30 | 2024 | Olumiant |
| Idorsia Pharmaceuticals US INC | $154.66 | 2023 | Quviviq |
| Arcutis Biotherapeutics, INC. | $121.55 | 2023 | |
| Genzyme Corporation | $111.81 | 2021 | |
| Supernus Pharmaceuticals, INC. | $97.24 | 2021-2025 | |
| Noctrix Health, INC. | $94.63 | 2024 | Nidra |
| Avadel Cns Pharmaceuticals, LLC | $94.01 | 2025 | Lumryz |
| Janssen Scientific Affairs, LLC | $92.31 | 2022 | |
| Axsome Therapeutics, INC. | $50.27 | 2023-2025 | Sunosi |
| Merck Sharp & Dohme LLC | $34.68 | 2022 | |
| Arbor Pharmaceuticals, INC. | $16.16 | 2019 | |
| Collegium Pharmaceutical, INC. | $14.72 | 2025 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Lebby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.